PK

Parvez Khan Saleem Khan Pathan

Active Director Director DIN 09043713
DIN 09043713 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Parvez Khan Saleem Khan Pathan

Data last updated:

Parvez Khan Saleem Khan Pathan is a Director at Synodor Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Synodor Pharmaceuticals Private Limited reported revenue of ₹1.3 Lakh (FY 2025).

DIN 09043713
Primary Designation Director
Industry Pharma
First Appointment 27 Jan 2021
Oldest Company Age 5 yrs
Largest company Synodor Pharmaceuticals Private Limited · ₹1.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20212021₹1.3 Lakh (FY 2025)Active

Board colleagues of Parvez Khan Saleem Khan Pathan

NameDINCompanyDesignation
Pathan09043714Synodor Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synodor Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parvez Khan Saleem Khan Pathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parvez Khan Saleem Khan Pathan

Parvez Khan Saleem Khan Pathan currently holds 1 directorship: Synodor Pharmaceuticals Private Limited (Director, since 27 Jan 2021, revenue ₹1.3 Lakh (FY 2025)).

Parvez Khan Saleem Khan Pathan was first appointed on 27 Jan 2021 as Director at Synodor Pharmaceuticals Private Limited.

The current boards of Parvez Khan Saleem Khan Pathan's companies include Pathan (Synodor Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available